Literature DB >> 15950912

Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities.

Raquel F Gerlach1, Juliana A Uzuelli, Caroline D Souza-Tarla, Jose E Tanus-Santos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15950912     DOI： 10.1016/j.ab.2005.04.038

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  25 in total

1.  Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model.

Authors:  Karina M Mata; Paula S Prudente; Fabio S Rocha; Cibele M Prado; Elaine M Floriano; Jorge Elias; Elen Rizzi; Raquel F Gerlach; Marcos A Rossi; Simone G Ramos
Journal:  Int J Exp Pathol       Date:  2010-10-29       Impact factor: 1.925

2.  The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome.

Authors:  Laura Lahdentausta; Timo Sorsa; Erkki Pesonen; Pirkko Pussinen
Journal:  J Cardiovasc Transl Res       Date:  2018-09-24       Impact factor: 4.132

3.  Serum or Plasma Matrix Metalloproteinase (MMP)-9 Levels and Cardiovascular Diseases.

Authors:  Indiara V Santana; Jose E Tanus-Santos
Journal:  J Cardiovasc Transl Res       Date:  2018-08-21       Impact factor: 4.132

4.  Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.

Authors:  Tatiane C Izidoro-Toledo; Danielle A Guimaraes; Vanessa A Belo; Raquel F Gerlach; Jose Eduardo Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-03-30       Impact factor: 3.000

Review 5.  Considerations for Soluble Protein Biomarker Blood Sample Matrix Selection.

Authors:  Joel A Mathews; Yan G Ni; Connie Wang; Jon E Peterson; Chad Ray; Xuemei Zhao; Daoyu Duan; Sara Hamon; John Allinson; Martha Hokom; Greta Wegner
Journal:  AAPS J       Date:  2020-01-29       Impact factor: 4.009

6.  Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.

Authors:  Fabio M Iwamoto; Andreas F Hottinger; Sasan Karimi; Elyn Riedel; Jocelynn Dantis; Maryam Jahdi; Katherine S Panageas; Andrew B Lassman; Lauren E Abrey; Martin Fleisher; Lisa M Deangelis; Eric C Holland; Adília Hormigo
Journal:  J Neurooncol       Date:  2011-06-28       Impact factor: 4.130

Review 7.  Before you analyze a human specimen, think quality, variability, and bias.

Authors:  Mark David Lim; Anthony Dickherber; Carolyn C Compton
Journal:  Anal Chem       Date:  2010-11-29       Impact factor: 6.986

8.  Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms.

Authors:  Cesar A Meschiari; Tatiane Izidoro-Toledo; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2013-03-03       Impact factor: 3.396

9.  Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity.

Authors:  Vanessa A Belo; Marcelo R Luizon; Patrícia C Carneiro; Valéria A Gomes; Riccardo Lacchini; Carla M M Lanna; Debora C Souza-Costa; Jose E Tanus-Santos
Journal:  Mol Biol Rep       Date:  2012-12-16       Impact factor: 2.316

10.  The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients.

Authors:  Kuvaja Paula; Talvensaari-Mattila Anne; Turpeenniemi-Hujanen Taina
Journal:  Biomark Insights       Date:  2007-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.